Opioid-Related Sexual Dysfunction in Men
- 54 Downloads
Purpose of Review
Opioids are the cornerstone for pain treatment with significant recent increases in the number of prescriptions. Sexual dysfunction (SD) is a major side effect of opioid therapy. The goal of this review is to examine the current literature on the effects of opioids on male SD (erectile dysfunction [ED], hypogonadism, ejaculatory dysfunction) and infertility.
High prevalence of SD exists in men with opioid use as compared to the general population, with an abundance of evidence suggesting an association between opioid use and ED and hypogonadism. There appears to be a role for testosterone replacement therapy for hypogonadism in men on opioid therapy. Screening for low testosterone levels is recommended in men on opioid therapy with signs and symptoms of androgen deficiency. Data on fertility, ejaculatory, and orgasmic dysfunction are limited.
SD is significantly affected by opioid therapy in men. Data demonstrate the benefits of screening for SD and treatment for hypogonadism.
KeywordsOpioid Sexual dysfunction Erectile dysfunction Ejaculatory dysfunction Premature ejaculation Opioid induced androgen deficiency (OPIAD)
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance
- 2.Gureje O, Von Korff M, Simon G. Persistent pain and wellbeing: a World Health Organization study in primary care. 1998:280: 147–151.Google Scholar
- 6.Davis A. Paracelsus: a quincetennial assessment. J R Soc Med. 1993;86:563–6.Google Scholar
- 7.Hayes AM, Gilbert SG. Historical milestones and discoveries that shaped the toxicology sciences. In: Molecular, clinical and environmental toxicology. Basel (Switzerland): Birkha ̈user Verlag AG. 2009. p. 1–35.Google Scholar
- 10.Rudd RA. Increases in drug and opioid overdose deaths—United States, 2000–2014. 2016:64:1378–1382.Google Scholar
- 11.Lugoboni F, Zamboni L, Federico A, Tamburin S, for the Gruppo InterSERT di Collaborazione Scientifica (GICS). Erectile dysfunction and quality of life in men receiving methadone or buprenorphine maintenance treatment. A cross-sectional multicentre study. Thumbikat P, editor. PLoS One 2017:12(11):e0188994.Google Scholar
- 15.• Yee A, Loh HS, Hisham Hashim HM b, Ng CG. The prevalence of sexual dysfunction among male patients on methadone and buprenorphine treatments: a meta-analysis study. J Sex Med. 2014;11(1):22–32. This meta-analysis consolidated multiple studies and provided statistical result to demonstrate a significantly higher risk of ED in men on methadone compared to buprenorphine therapy. CrossRefPubMedGoogle Scholar
- 16.• Zhao S, Deng T, Luo L, Wang J, Li E, Liu L, et al. Association between opioid use and risk of erectile dysfunction: a systematic review and meta-analysis. J Sex Med. 2017;14(10):1209–19. This meta-analysis included ten studies, many of which were included in our review, and provided statistical result demonstrating an increased risk of ED associated with opioid use. CrossRefPubMedGoogle Scholar
- 22.• Bawor M, Bami H, Dennis BB, Plater C, Worster A, Varenbut M, et al. Testosterone suppression in opioid users: a systematic review and meta-analysis. Drug Alcohol Depend. 2015;1–9:149. This meta-analysis provides evidence to support the statistical correlation between opioid use and low testosterone. Google Scholar
- 34.Zhang M, Zhang H, Shi CX, McGoogan JM, Zhang B, Zhao L, et al. Sexual dysfunction improved in heroin-dependent men after methadone maintenance treatment in Tianjin, China. Chang AYW, editor PLoS One 2014:9(2):e88289.Google Scholar
- 35.Somani B, Khan S, Donat R. Screening for metabolic syndrome and testosterone deficiency in patients with erectile dysfunction: results from the first UK prospective study: Screening metabolic syndrome and testosterone and testosterone deficiency in men with ED. BJU Int. 2010;106(5):688–90.CrossRefPubMedGoogle Scholar
- 36.Babakhanian M, Haghdoost AA, Afshari M, Taghizadeh F, Moosazadeh M. Methadone replacement therapy and sexual disorders among opium dependent Iranian men: a meta-analysis health 2017: 9(1):10.Google Scholar
- 40.Yee A, Danaee M, Loh HS, Sulaiman AH, Ng CG. Sexual dysfunction in heroin dependents: a comparison between methadone and buprenorphine maintenance treatment. Dominguez JM, editor PloS One 2016:11(1):e0147852.Google Scholar
- 49.Rubinstein AL, Carpenter DM. Association between commonly prescribed opioids and androgen deficiency in men: a retrospective cohort analysis. Pain Med. 2016:pnw182.Google Scholar
- 54.Grover S, Mattoo S, Pendharkar S, Kandappan V. Sexual dysfunction in patients with alcohol and opioid dependence. Indian J Psychol Med 2014:15:36(4):355–65.Google Scholar
- 55.Serefoglu EC, McMahon CG, Waldinger MD, Althof SE, Shindel A, Adaikan G, et al. An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the Second International Society for Sexual Medicine Ad Hoc Committee for the Definition of Premature Ejaculation. Sex Med. 2014;2(2):41–59.CrossRefPubMedPubMedCentralGoogle Scholar
- 63.Subirán N, Casis L, Irazusta J. Regulation of male fertility by the opioid system. Mol Med. 2011;12(7–8):846–53.Google Scholar